Genotyping: A new application for the spent dialysate in peritoneal dialysis

Nephrology Dialysis Transplantation

Volumn 19, Issue 5, 2004, Pages 1298-1301

  Gillerot, Gaëlle ^a   Debaix, Huguette ^a   Devuyst, Olivier ^a  

^a UNIVERSITY OF LOUVAIN MEDICAL SCHOOL   (Belgium)

Author keywords

DNA; PCR; Peritoneal dialysis; PET; Polymorphism

Indexed keywords

ASPARTIC ACID; CYTOKINE; DNA; DNA POLYMERASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUTAMIC ACID; GROWTH FACTOR;

ARTICLE; BACTERIOPHAGE; BLOOD ANALYSIS; CELL CULTURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIALYSATE; DNA EXTRACTION; GENE AMPLIFICATION; GENETIC POLYMORPHISM; GENOTYPE; HEMODIALYSIS PATIENT; HUMAN; HYPOTHESIS; LOW TEMPERATURE PROCEDURES; PERITONEAL DIALYSIS; PERITONEUM CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RELIABILITY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEQUENCE ANALYSIS;

BASE SEQUENCE; DIALYSIS SOLUTIONS; DNA; DNA PRIMERS; GENOTYPE; HUMANS; PERITONEAL CAVITY; PERITONEAL DIALYSIS; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

EID: 2442424059     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfh017     Document Type: Article

References (18)

1. Twadowski ZJ. PET - a simpler approach for determining prescriptions for adequate peritoneal dialysis. Adv Perit Dial 1990; 134: 124-132
2. Churchill DN, Thorpe KE, Nolph KD et al. Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. The Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol 1998; 9: 1285-1292
3. Pecoits-Filho R, Araujo MR, Lindholm B et al. Plasma and dialysate IL-6 and VEGF concentrations are associated with high peritoneal solute transport rate. Nephrol Dial Transplant 2002; 17: 1480-1486
4. Zweers MM, de Waart DR, Smit W et al. Growth factors VEGF and TGF-β in peritoneal dialysis. J Lab Clin Med 1999; 134: 124-132
5. Krediet RT. Dialysate cancer antigen 125 concentration as marker of peritoneal membrane status in patients treated with chronic peritoneal dialysis. Perit Dial Int 2001; 21: 560-567
6. Mandl-Weber S, Cohen CD, Haslinger B et al. Vascular endothelial growth factor production and regulation in human peritoneal mesothelial cells. Kidney Int 2002; 61: 570-578
7. Gotlib L, Shostak A, Wajsbrot V. Functional structure of the peritoneum as a dialysing membrane. In: Gokal R, Khanna R, Krediet RT, Nolph KD, eds. Textbook of Peritoneal Dialysis. Kluwer Academic Publishers, Dordrecht; 2000: 71-73
8. Janez-Mo M, Lara-Pezzi E, Selgas R et al. Peritonea] dialysis and epithelial-to-mesenchymal transition of mesothelial cells. N Engl J Med 2003; 348: 403-413
9. Miyata T, Devuyst O, Kurokawa K, van Ypersele de Strihou C. Toward better dialysis compatibility: advances in the biochemistry and pathophysiology of the peritoneal membranes. Kidney Int 2002; 61: 375-386
10. Devuyst O. New insights in the molecular mechanisms regulating peritoneal permeability. Nephrol Dial Transplant. 2002; 17: 548-551
11. Wang XL, Sim AS, Badenhop RF et al. A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide gene. Nature Med 1996; 2: 41-45
12. Miyamoto Y, Saito Y, Kajiyama N et al. Endothelial nitric oxide synthase gene is positively associated with essential hypertension. Hypertension 1998; 32: 3-8
13. Watson C, Webb NJ, Bottomley MJ, Brenchley PE. Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine 2000; 12: 1232-1235
14. Shahbazi M, Fryer AA, Pravica et al. Vascular endothelial growth factor gene polymorphisms are associated with acute renal allograft rejection. J Am Soc Nephrol 2002; 13: 260-264
15. Davies SJ. Peritoneal solute transport: we know it is important, but what is it? Nephrol Dial Transplant 2000; 15: 1120-1123
16. Human Tissue and Biological Samples for Use in Research. MRC Ethics Series. The Medical Research Council; 2001
17. Persu A, Stoenoiu MS, Messiaen T et al. Modifier effect of ENOS in autosomal dominant polycystic kidney disease. Hum Mol Genet 2002; 11: 229-241
18. Leeson CP, Hingorani AD, Mullen MJ et al. Glu298Asp endothelial nitric oxide synthase gene polymorphism interacts with environmental and dietary factors to influence endothelial function. Circ Res 2002; 90: 1153-1158